Yuewu Shen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Antibody-based immunotherapy has been effectively used for tumor treatment. However, to date, only a few tumor-associated antigens (TAAs) or therapeutic targets have been identified. Identification of more immunogenic antigens is essential for improvements in multiple myeloma (MM) diagnosis and therapy. In this study, we synthesized a polyclonal antibody(More)
  • 1